NCT00003268View on ClinicalTrials.gov

Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 1998

Study Completion Date

December 31, 2003

Conditions

Drug/Agent Toxicity by Tissue/OrganLeukemia

Interventions

DRUG

amifostine trihydrate

DRUG

cytarabine

DRUG

idarubicin

Trial Locations (1)

19107-5541

Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia

All Listed Sponsors

lead

Sidney Kimmel Cancer Center at Thomas Jefferson University

OTHER

NCT00003268 - Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter